Showing results (61-70 of 90) with videos related to
Sort By:
Pageof 9
European Journal of Cancer (Oxford, England : 1990)|April 1, 1997
Medroxyprogesterone acetate reduces the in vitro production of cytokines and serotonin involved in anorexia/cachexia and emesis by peripheral blood mononuclear cells of cancer patientsG Mantovani, A Macciò, S Esu, et al.Transplantation Proceedings|November 14, 2012
Course and outcome of renal transplant recipients admitted to the intensive care unit: a 20-year studyE Mouloudi, E Massa, E Georgiadou, et al.Oncology Reports|December 7, 2002
Multicenter phase II study of fractionated bimonthly oxaliplatin with leucovorin and 5-fluorouracil in patients with metastatic colorectal cancer, pre-treated with chemotherapyF Recchia, S Rea, A Nuzzo, et al.Journal of Molecular Medicine (Berlin, Germany)|July 24, 2001
Serum values of proinflammatory cytokines are inversely correlated with serum leptin levels in patients with advanced stage cancer at different sitesG Mantovani, A Macciò, C Madeddu, et al.Transplantation Proceedings|November 14, 2012
Infections related to renal transplantation requiring intensive care admission: a 20-year studyE Mouloudi, E Massa, E Georgiadou, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|April 4, 2000
Results of a dose-intense phase 1 study of a combination chemotherapy regimen with cisplatin and epidoxorubicin including medroxyprogesterone acetate and recombinant interleukin-2 in patients with inoperable primary lung cancerG Mantovani, A Macciò, P Lai, et al.International Journal of Oncology|May 5, 2011
Neo-adjuvant organ-preserving chemotherapy in the management of locally advanced oral cavity and oropharynx cancerG Mantovani, V Gebbia, E Proto, et al.International Journal of Oncology|February 15, 2001
Immunotherapy (recombinant interleukin 2), hormone therapy (medroxyprogesterone acetate) and antioxidant agents as combined maintenance treatment of responders to previous chemotherapyG Mantovani, A Maccio, C Madeddu, et al.International Journal of Oncology|May 5, 2011
Neo-adjuvant (primary) organ-preserving chemotherapy in the management of locally advanced laryngeal carcinomaG Mantovani, V Gebbia, E Proto, et al.Journal of Neonatal-Perinatal Medicine|August 6, 2025
Cardiac output during flow-titrated high-flow nasal cannula support in a neonatal porcine modelCory Templeton, Yosef Levenbrown, Anne M Hesek, et al.Pageof 9